Our co-founder, Professor Dr. Melik C. Demirel, authored an influential essay on public policy, using the narrative of Tandem Repeat as an illustrative case study. https://lnkd.in/enS4nmG9
Can deep tech products be manufactured in the USA? I collaborated with David Adler on a public policy essay regarding this issue, which is now available in American Affairs. Initially, it offers examples of advancing through the technology readiness levels (TRL), using a real case from Tandem Repeat, which I founded. Following that, it delves into the specifics of a policy solution, introducing a new concept: Public Policy Readiness Level (PRL). This topic is crucial for discussing policy areas, including the National Security Commission on Emerging Biotechnology (NSCEB), such as infrastructure, scaling, data management, strategic financing and investment, standardization, partnership collaborations, and regulation of biotech products. Please leave your comments below. I’m happy to chat if you’re interested in this topic.